pRESET LITE 取栓装置在联合方法治疗中等血管闭塞中的应用:一项多中心评估
本研究回顾性分析了 MAD MT 联盟 37 家中心 2016 年 9 月至 2021 年 12 月收治的 227 例原发性中等血管闭塞(MeVO)急性缺血性卒中患者,使用 pRESET LITE 支架取栓器行机械取栓,96% 病例采用联合方法。近端 MeVO 成功再灌注率 85%,远端 MeVO 97%,总体中位通过次数 2 次,围手术期并发症率 7%,3 个月良好预后率 58%(远端 MeVO 63%)。
要点
- pRESET LITE 联合抽吸导管治疗原发性 MeVO 的总体成功再灌注率较高(近端 85%,远端 97%)。
- 术后第 1 天 CT 显示出血转化率近端 MeVO 39%、远端 MeVO 36%,ECASS-PH 型仅 1%。
- 3 个月良好预后(mRS 0-2)总体 58%,远端 MeVO 达 63%。
核心结论
- 使用 pRESET LITE 联合抽吸导管的机械取栓方法对原发性中等血管闭塞在多中心、多术者条件下似乎有效。
研究设计与样本
- 回顾性分析 MAD MT 联盟(整合欧洲、北美和亚洲 37 家学术机构前瞻性维护的数据库),纳入 2016 年 9 月至 2021 年 12 月 227 例原发性 MeVO 的 AIS 患者,均使用 pRESET LITE 支架取栓器行机械取栓。
关键影像表现/征象
- 将闭塞分为近端 MeVO(A1、M2、P1 段)与远端 MeVO/DMVO(A2、M3-M4、P2 段)。
- 术后第 1 天 CT 显示近端 MeVO 出血转化 63 例(39%),远端 MeVO 24 例(36%),ECASS-PH 型出血转化 3 例(1%)。
诊断标准与关键数值
- 成功再灌注定义为 mTICI 2b/2c/3,近端 MeVO 达 85%,远端 MeVO 达 97%。
- 总体中位通过次数为 2 次(IQR 1-3)。
- 围手术期并发症率为 7%。
- 3 个月良好预后定义为 mRS 0-2,所有 MeVO 为 58%,远端 MeVO 为 63%。
临床应用与阅片要点
- 96% 的病例采用 pRESET LITE 联合抽吸导管的联合方法。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Our purpose was to assess the efficacy and safety of the pRESET LITE stent retriever (Phenox, Bochum, Germany), designed for medium vessel occlusion (MeVO) in acute ischemic stroke (AIS) patients with a primary MeVO.
METHODS: We performed a retrospective analysis of the MAD MT Consortium, an integration of prospectively maintained databases at 37 academic institutions in Europe, North America, and Asia, of AIS patients who underwent mechanical thrombectomy with the pRESET LITE stent retriever for a primary MeVO. We subcategorized occlusions into proximal MeVOs (segments A1, M2, and P1) vs. distal MeVOs/DMVO (segments A2, M3-M4, and P2). We reviewed patient and procedural characteristics, as well as angiographic and clinical outcomes.
RESULTS: Between September 2016 and December 2021, 227 patients were included (50% female, median age 78 [65-84] years), of whom 161 (71%) suffered proximal MeVO and 66 (29%) distal MeVO. Using a combined approach in 96% of cases, successful reperfusion of the target vessel (mTICI 2b/2c/3) was attained in 85% of proximal MeVO and 97% of DMVO, with a median of 2 passes (IQR: 1-3) overall. Periprocedural complications rate was 7%. Control CT at day 1 post-MT revealed a hemorrhagic transformation in 63 (39%) patients with proximal MeVO and 24 (36%) patients with DMVO, with ECASS-PH type hemorrhagic transformations occurring in 3 (1%) patients. After 3 months, 58% of all MeVO and 63% of DMVO patients demonstrated a favorable outcome (mRS 0-2).
CONCLUSION: Mechanical thrombectomy using the pRESET LITE in a combined approach with an aspiration catheter appears effective for primary medium vessel occlusions across several centers and physicians.
引用
- Wang M, Henkes H, Ghozy S, et al. Use of the pRESET LITE thrombectomy device in combined approach for medium vessel occlusions: A multicenter evaluation. Neuroradiology. 2024. PMID: 38381145. doi:10.1007/s00234-024-03302-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。